| Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set-E-Book WR Jarnagin Elsevier Health Sciences, 2022 | 140 | 2022 |
| Park the Parking N Premnath, US Grewal, A Gupta JCO Oncology Practice, OP. 20.00065, 2020 | 12 | 2020 |
| Dissemination of information on neutropenic diet by top US cancer centers: in-line with the evidence? TJ Brown, D Mukhija, N Premnath, A Venkatraman, S Jiv Singh Nagpal, ... Nutrition and cancer 71 (8), 1272-1275, 2019 | 9 | 2019 |
| BReast CAncer (BRCA) gene mutations as an emerging biomarker for the treatment of gastrointestinal malignancies N Premnath, EM O’Reilly Chinese Clinical Oncology 9 (5), 64-64, 2020 | 7 | 2020 |
| Projected 30-day out-of-pocket costs and total spending on pancreatic enzyme replacement therapy under Medicare Part D A Gupta, N Premnath, R Sedhom, MS Beg, R Khera, DA Laheru, ... Pancreatology 21 (5), 1009-1010, 2021 | 6 | 2021 |
| Analysis of the impact of COVID-19 pandemic on house-staff in the USA: addressing the ripple effects US Grewal, N Premnath, N Bhardwaj, AR Sheth, SC Garikipati, ... Journal of Community Hospital Internal Medicine Perspectives 11 (4), 476-479, 2021 | 6 | 2021 |
| Projected 30-day out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D. A Gupta, N Premnath, MS Beg, R Khera, S Dusetzina Journal of Clinical Oncology 39 (3_suppl), 401-401, 2021 | 6 | 2021 |
| Use of peripheral μ-opioid receptor antagonists for treating opioid-induced constipation among US Medicare beneficiaries from 2014 to 2018 N Premnath, A Sumarsono, R Sedhom, DH Johnson, IM Subbiah, SM Dy, ... Journal of palliative medicine 24 (8), 1236-1239, 2021 | 5 | 2021 |
| Potential cost savings with low-dose abiraterone in the United States N Premnath, R Sedhom, A Gupta JCO Global Oncology 6, 2020 | 5 | 2020 |
| Trends in outcomes of patients with metastatic cancer undergoing intubation and mechanical ventilation: results of the national hospital discharge survey A Gupta, A Das, R Tariq, N Bhulani, N Premnath, D Solanky, RD Frank, ... Journal of the National Comprehensive Cancer Network 16 (3), 286-292, 2018 | 5 | 2018 |
| Assessment of racial differences in rates of autopsy in the US, 2008-2017 A Gupta, N Premnath, PL Kuo, R Sedhom, OW Brawley, F Chino JAMA internal medicine 180 (8), 1123-1124, 2020 | 4 | 2020 |
| Paradigm shift in the management of acute myeloid leukemia—approved options in 2023 N Premnath, YF Madanat Cancers 15 (11), 3002, 2023 | 3 | 2023 |
| Novel investigational agents and pathways that May influence the Future Management of Acute myeloid leukemia N Premnath, YF Madanat Cancers 15 (11), 2958, 2023 | 3 | 2023 |
| Clinical and molecular characteristics associated with Vitamin C deficiency in myeloid malignancies; real world data from a prospective cohort N Premnath, SS Chung, O Weinberg, R Ikpefan, M Pandey, G Kaur, ... Leukemia Research, 107001, 2022 | 3 | 2022 |
| Possible role of IL‐23 inhibitor in autoimmune hemolytic anemia N Premnath, U Pandey, M Pandey, K Venuprasad European Journal of Haematology 111 (3), 506-508, 2023 | 2 | 2023 |
| COVID vaccine antibody responses in patients with hematologic malignancies in a myeloid enriched cohort: a better antibody response in patients with myeloid malignancies than B … SY Goksu, J Rolwes, N Premnath, P Patel, R Ikpefan, G Kaur, ... Blood 138, 4134, 2021 | 2 | 2021 |
| Clonal hematopoiesis and heart failure with preserved ejection fraction T Thomas, Y Ji, F Kalkan, A Son, A Pandey, V Subramanian, N Premnath, ... Blood 140 (Supplement 1), 8611-8612, 2022 | 1 | 2022 |
| Clinical and Molecular Characteristics Associated with Vitamin C Deficiency in Myeloid Malignancies; Real World Data from a Prospective Cohort N Premnath, S Chung, SY Goksu, P Patel, R Ikpefan, J Rolwes, M Pandey, ... Blood 138, 1217, 2021 | 1 | 2021 |
| Dissemination of information on neutropenic diet (ND) by top US cancer centers: In line with evidence? D Mukhija, N Premnath, A Gupta, A Venkatraman, SJS Nagpal Journal of Clinical Oncology 36 (15_suppl), e18940-e18940, 2018 | 1 | 2018 |
| Abstract PO4-06-13: Palliative care utilization in triple negative metastatic breast cancer patients and impact on survival: A nationwide analysis S Kashanian, S Kanjwal, LS Brown, N Premnath, N Sadeghi Cancer Research 84 (9_Supplement), PO4-06-13-PO4-06-13, 2024 | | 2024 |
